Ten years change in post-fracture care for hip fracture patients.
Ten years change in post-fracture care for hip fracture patients.
Ten years change in post-fracture care for hip fracture patients.
In-vitro comparison of hydroxyapatite coatings obtained by cold spray and conventional thermal spray technologies
Long term effects on biochemical bone markers of a single infusion of zoledronic acid in Paget disease of bone.
Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis.
Osteopenia and Osteoporosis in Patients with Bronchiectasis: Association with Respiratory Parameters, Body Composition, Muscle Strength and Bone Remodeling Biomarkers.
Increased Fracture Risk in Women Treated With Aromatase Inhibitors Versus Tamoxifen: Beneficial Effect of Bisphosphonates.
Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: Systematic review and meta- analysis.
Targeting Macrophages: Friends or Foes in Disease? Front Pharmacol.
Periostin and sclerostin levels in individuals with spinal cord injury and their relationship with bone mass, bone turnover, fracture and osteoporosis status.
Analysis of bone impairment by 3D DXA hip measures in patients with primary hyperparathyroidism: a pilot study.